← Back to Drug List

CILOSTAZOL TAB

Clinical Criteria Summary

Exclusion Criteria

  • Heart failure with reduced ejection fraction (FDA labeling does not specify the classification or degree of heart failure severity that should be avoided; concern is based on extrapolated data from oral milrinone where patients with class III and IV heart failure with reduced ejection fraction had lower survival)

Source Documents